{"schema_version":"1","generated_at":"2026-11-01T06:18:22.306Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/fang-liu","json_url":"https://www.findmykol.com/kol/fang-liu/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"fang-liu","name":"Fang Liu","credential":"MD","title":"Internist, Marietta GA (third-party listing; specialty conflicts with the hematology board note on the same page)","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Leukemia","therapeutic_areas":["Leukemia","Lymphoma","Lung","Myeloma"],"institution":"Northwest Georgia Oncology Centers","institution_url":"https://www.findmykol.com/institution/northwest-georgia-oncology-centers","city":"Marietta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1932581535"},"summary":"Fang Liu is Internist, Marietta GA (third-party listing; specialty conflicts with the hematology board note on the same page) at Northwest Georgia Oncology Centers. ClinicalTrials.gov lists 26 registered studies with this person as an investigator.","overview":{"text":"Fang Liu, M.D., is Internist, Marietta GA (third-party listing at Northwest Georgia Oncology Centers. It also documents an investigator role on 26 registered clinical trials, industry payments reported by 17 companies.","bullets":["Top research focus: Leukemia (AML/ALL/CML/CLL)","26 registered trials on ClinicalTrials.gov","Open Payments reporting from 17 companies"],"generated_at":"2026-10-31"},"focus":{"indications":[{"label":"Mucocutaneous Lymph Node Syndrome","therapeutic_area":"Cardiology","trials":7,"topics":0,"strength":21},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Aneurysm","therapeutic_area":"Cardiology","trials":3,"topics":0,"strength":9},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Recurrence","therapeutic_area":"Epidemiology","trials":2,"topics":0,"strength":6},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Leukemia, Myeloid, Acute","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Hematologic Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Type 2 Diabetes","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Diabetic Complications","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Diabetic Nephropathies","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Asthenia","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Stroke","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Tics","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Leukemia (AML/ALL/CML/CLL)","Lymphoma","Hematologic Neoplasms","Leukemia, Myeloid, Acute","Lung Cancer (NSCLC/SCLC)","MDS / MPN","Multiple Myeloma","Small Cell Lung Carcinoma","Brain Neoplasms","Lymphoma, T-Cell","Neoplasm Metastasis"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Brukinsa","generic":"Zanubrutinib","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Enhertu","generic":"Trastuzumab","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Jemperli","generic":"Dostarlimab","trials":0,"payments":3,"publications":0,"mentions":3}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Children's Hospital of Fudan University","trials":7,"payments":0,"mentions":7},{"name":"iCell Gene Therapeutics","trials":7,"payments":0,"mentions":7},{"name":"Janssen Biotech, Inc.","trials":0,"payments":4,"mentions":4}]}},"scholarship":{"h_index":0,"pubmed_count":0,"latest_activity_year":2025,"source":"works"},"trials":{"count":26,"shown":3,"withheld":23,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07686770","title":"Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease","phase":"PHASE2/PHASE3","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Children's Hospital of Fudan University","source_url":"https://clinicaltrials.gov/study/NCT07686770","trial_url":"https://www.findmykol.com/trial/NCT07686770"},{"nct":"NCT07398560","title":"Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"The Third Affiliated Hospital of Harbin Medical University","source_url":"https://clinicaltrials.gov/study/NCT07398560","trial_url":"https://www.findmykol.com/trial/NCT07398560"},{"nct":"NCT06993636","title":"Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years","status":"RECRUITING","role":"Investigator","sponsor":"Children's Hospital of Fudan University","source_url":"https://clinicaltrials.gov/study/NCT06993636","trial_url":"https://www.findmykol.com/trial/NCT06993636"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":2025},"rows_total":20,"shown":3,"withheld":17,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":84.8,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932581535"},{"payer":"BeOne Medicines USA, Inc.","program_year":2025,"amount_usd":60.96,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932581535"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":54.02,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932581535"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1932581535","source":"payments"},"prescribing":{"data_year":2024,"areas_total":10,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":57.6,"classes_total":10,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":25.5,"drugs":[{"name":"Anastrozole","share_pct":80},{"name":"Letrozole","share_pct":16.5},{"name":"Exemestane","share_pct":3.4}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":12.7,"drugs":[{"name":"Calquence","share_pct":18.5},{"name":"Ibrance","share_pct":15.3},{"name":"Verzenio","share_pct":12.9},{"name":"Jakafi","share_pct":11.7},{"name":"Cabometyx","share_pct":10.1},{"name":"Imbruvica","share_pct":7.7},{"name":"Imatinib Mesylate","share_pct":7.3},{"name":"Brukinsa","share_pct":6},{"name":"Kisqali","share_pct":5.2},{"name":"Tasigna","share_pct":5.2}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":16.2,"classes_total":7,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":42},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":2.6,"drugs":[{"name":"Ondansetron Hcl","share_pct":76},{"name":"Ondansetron Odt","share_pct":24}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":10,"classes_total":3,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":7.6,"drugs":[{"name":"Eliquis","share_pct":60.4},{"name":"Xarelto","share_pct":39.6}],"max_beneficiaries":24},{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":1.7,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":69.9,"facility_pct":30.1},"source":"medicare"},"funding":{"award_count":0,"rows_total":32,"shown":3,"withheld":29,"rows":[{"project":"R01AR079442","title":"Deep Learning Technology for Rapid Morphological and Quantitative Imaging of Knee Pathology","fiscal_year":2026,"amount_usd":489683,"organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01AR079442"},{"project":"R01AR081344","title":"Rapid Three-dimensional Simultaneous Knee Multi-Relaxation Mapping","fiscal_year":2026,"amount_usd":369383,"organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01AR081344"},{"project":"R01AR079442","title":"Deep Learning Technology for Rapid Morphological and Quantitative Imaging of Knee Pathology","fiscal_year":2025,"amount_usd":499992,"organization":"MASSACHUSETTS GENERAL HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01AR079442"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD","source_url":"https://connect.medicalnewstoday.com/provider/dr-fang-liu-1932581535","status":"provisional","collected_at":"2026-10-31"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Wellstar Kennestone Regional Medical Center","source_url":"https://connect.medicalnewstoday.com/provider/dr-fang-liu-1932581535","status":"provisional","collected_at":"2026-10-31"}]}},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Jorge Cortes","slug":"jorge-cortes","institution":"University of Alabama at Birmingham (UAB)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/jorge-cortes","json_url":"https://www.findmykol.com/kol/jorge-cortes/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":23,"payments":17,"funding":29}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-31"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-31"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-31"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}